Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 11/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.60 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.55 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30924111 | 0.93 | CHRM4 (0.61) | CHRM4CHRM2CHRM1PTBP1EPHX2 | |
| SCHEMBL30923923 | 0.87 | EPHX2 (0.60) | CHRM4CHRM2CHRM1PTBP1ACKR3 | |
| SCHEMBL31716864 | 0.85 | KDM4E (0.56) | CHRM4CHRM2EPHX2 | |
| SCHEMBL30924025 | 0.85 | CACNA1G (0.59) | CHRM4CHRM2CHRM1PTBP1EPHX2 | |
| SCHEMBL30924123 | 0.84 | CHRM2 (0.59) | CHRM4CHRM2CHRM1ACKR3 | |
| SCHEMBL30924054 | 0.84 | EPHX2 (0.57) | CHRM4CHRM2CHRM1PTBP1EPHX2 | |
| SCHEMBL30924162 | 0.83 | EPHX2 (0.59) | CHRM4CHRM2CHRM1EPHX2 | |
| SCHEMBL30924112 | 0.83 | EPHX2 (0.77) | CHRM4EPHX2 | |
| SCHEMBL30924024 | 0.83 | ACKR3 (0.55) | CHRM4CHRM2CHRM1PTBP1ACKR3 | |
| SCHEMBL30924135 | 0.81 | BCHE (0.61) | CHRM4ACKR3EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4618985-A1 | DUAL INHIBITORS OF SIGMA-1 RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE AND THEIR USE IN THE TREATMENT OF PAIN | Universitat De Barcelona (ES) | 2025-09-24 | — | — | EP | disclosed |
| WO-2024105234-A1 | DUAL INHIBITORS OF SIGMA-1 RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE AND THEIR USE IN THE TREATMENT OF PAIN | UNIVERSITAT DE BARCELONA (ES) | 2024-05-23 | — | — | WO | disclosed |